Oncomatryx at the «Cancer Metabolism and the Tumour Microenvironment Conference».
9-12, November. Paphos, Cyprus.
Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the conference as speaker:
TARGETING TUMOR MICROENVIRONMENT TO TREAT INVASIVE TUMORS: OMTX705, A POWERFUL FAP-SPECIFIC ANTIBODY-DRUG CONJUGATE.
If you are also attending the conference and would like to meet us please fill this form to arrange an appointment.
[contact-form-7 id=»2869″ title=»conference appointment»]